Entity Details

Primary name CRBB3_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP26998
EntryNameCRBB3_HUMAN
FullNameBeta-crystallin B3
TaxID9606
Evidenceevidence at protein level
Length211
SequenceStatuscomplete
DateCreated1992-08-01
DateModified2021-06-02

Ontological Relatives

GenesCRYBB3

GO terms

Show/Hide Table
GOName
GO:0002088 lens development in camera-type eye
GO:0005212 structural constituent of eye lens
GO:0007601 visual perception

Subcellular Location

Show/Hide Table

Domains

Show/Hide Table
DomainNameCategoryType
IPR001064 Beta/gamma crystallinDomainDomain
IPR011024 Gamma-crystallin-likeFamilyHomologous superfamily
IPR033115 Beta-crystallin B3FamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
609741 OMIMCataract 22, multiple types (CTRCT22)An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT22 includes nuclear cataract among others. Nuclear cataracts affect the central nucleus of the eye, and are often not highly visually significant. The density of the opacities varies greatly from fine dots to a dense, white and chalk-like, central cataract. The condition is usually bilateral. Nuclear cataracts are often combined with opacified cortical fibers encircling the nuclear opacity, which are referred to as cortical riders. The disease is caused by variants affecting the gene represented in this entry.